Extended Data Fig. 10: Cocaine treatment of MISCOs. | Nature Methods

Extended Data Fig. 10: Cocaine treatment of MISCOs.

From: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids

Extended Data Fig. 10

a, Representative GCAMP recordings of 130-day-old MISCOs with Syn-GCAMP expression either in the cortical or striatal tissue in control (left), chronic (middle) and withdrawal (right) condition. b, Representative GCAMP-recording of a MISCO with Syn-GCAMP in striatal tissue before (control) and after TTX application (0.5 µM), visualized as cumulative neuronal activity in a 6.5 min recording and displayed as ΔF/F. c, Calcium event duration of VM neurons in control, chronic and withdrawal conditions. 876|2058|1068 individual calcium events of 7-17 organoids. All Padj < 0.0001. d, Analysis of calcium event frequency of VM (n = 100|278|115) neurons in control, chronic and withdrawal conditions. Padj = 0.0341|0.002|< 0.0001. Data shown as mean ± SD. Samples were analyzed by one-way ANOVA followed by Tukey’s multiple comparisons test (c,d). e-f, Volcano plots of differentially expressed genes in VM tissue in chronic versus control (e) and withdrawal versus control (f). P-value was calculated using a Benjamin-Hochberg corrected Wald test using DESeq2. g-i, GSEA analysis of three GO terms associated with neural circuit formation (dendrite development, axon development and synapse organization) in forebrain chronic vs control (top) and forebrain withdrawal versus control (bottom).

Source data

Back to article page